Promoting Quality in Drug Manufacturing

September 2, 2004
Jill Wechsler
Pharmaceutical Technology

Volume 28, Issue 9

FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.